Male Infertility and Testicular Cancer – Points of Common Causality Int J Androl, 2007;30:406–11, discussion 412. 7. 8.
Jacobsen R, Bostofte E, Engholm G, et al., Risk of testicular cancer in men with abnormal semen characteristics: cohort study, Br Med J, 2000;321:789–92.
Raman JD, Nobert CF, Goldstein M, Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis, J Urol, 2005;174:1819–22, discussion 1822.
9.
Paul C, Povey JE, Lawrence NJ, et al., Deletion of genes implicated in protecting the integrity of male germ cells has differential effects on the incidence of DNA breaks and germ cell loss, PLoS One, 2007;2:e989.
10.
Uehara S, Hashiyada M, Sato K, et al., Complete XY gonadal dysgenesis and aspects of the SRYgenotype and gonadal tumor formation, J Hum Genet, 2002;47: 279–84.
11.
Hughes CM, Lewis SE, McKelvey-Martin VJ, Thompson W, A comparison of baseline and induced DNA damage in human spermatozoa from fertile and infertile men, using a modified comet assay, Mol Hum Reprod, 1996;2:613–19.
12.
Devouassoux-Shisheboran M, Mauduit C, Bouvier R, et al., Expression of hMLH1 and hMSH2 and assessment of microsatellite instability in testicular and mediastinal germ cell tumours, Mol Hum Reprod, 2001;7: 1099–1105.
13.
Fenton RG, Longo DL, Cancer cell biology and angiogenesis. In: Fauci AS, Braunwald E, Kasper DL, et
14.
al. (eds), Harrison’s Principles of Internal Medicine, 17th edn, McGraw-Hill, 2008.
Tourtellotte WG, Nagarajan R, Auyeung A, et al., Infertility associated with incomplete spermatogenic arrest and oligozoospermia in Egr4-deficient mice, Development, 1999;126:5061–71.
15. 16. 17. 18. 19. 20.
Ge RS, Chen GR, Tanrikut C, Hardy MP, Phthalate ester toxicity in Leydig cells: developmental timing and dosage considerations, Reprod Toxicol, 2007;23:366–73.
Wohlfahrt-Veje C, Main KM, Skakkebaek NE, Testicular dysgenesis syndrome; fetal origin of adult reproductive problems, Clin Endocrinol (Oxf), 2009;71(4):459–65.
Rorth M, Rajpert-De Meyts E, Andersson L, et al., Carcinoma in situ in the testis, Scand J Urol Nephrol, 2000;205(Suppl.):166–86.
Docimo SG, Silver RI, Cromie W, The undescended testicle: diagnosis and management, Am Fam Physician, 2000;62:2037–44, 2047–8.
Lu CC, Steinberger A, Effects of estrogen on human seminiferous tubules: light and electron microscopic analysis, Am J Anat, 1978;153:1–13.
Fowler KA, Gill K, Kirma N, Dillehay DL, Tekmal RR, Overexpression of aromatase leads to development of testicular Leydig cell tumors: an in vivo model for hormone-mediated testicular cancer, Am J Pathol, 2000;156:347–53.
21.
Skakkebaek NE, Rajpert-De Meyts E, Main KM, Testicular dysgenesis syndrome: an increasingly common
24. 22. 23.
developmental disorder with environmental aspects, Hum Reprod, 2001;16:972–8.
Weir HK, Marrett LD, Kreiger N, et al., Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer, Int J Cancer, 2000;87:438–43.
Pierik FH, Burdorf A, Deddens JA, et al., Maternal and paternal risk factors for cryptorchidism and hypospadias: a case–control study in newborn boys, Environ Health Perspect, 2004;112:1570–76.
Andersen HR, Schmidt IM, Grandjean P, et al., Impaired reproductive development in sons of women occupationally exposed to pesticides during pregnancy, Environ Health Perspect, 2008;116:566–72.
25.
Andersson AM, Jorgensen N, Frydelund-Larsen L, et al., Impaired Leydig cell function in infertile men: a study of 357 idiopathic infertile men and 318 proven fertile controls, J Clin Endocrinol Metab, 2004;89:3161–7.
26. 27.
Petersen PM, Giwercman A, Hansen SW, et al., Impaired testicular function in patients with carcinoma-in-situ of the testis, J Clin Oncol, 1999;17:173–9.
Ferrara D, Hallmark N, Scott H, et al., Acute and long-term effects of in utero exposure of rats to di(n- butyl) phthalate on testicular germ cell development and proliferation, Endocrinology, 2006;147:5352–62.
28.
Gray LE Jr, Wilson VS, Stoker T, et al., Adverse effects of environmental antiandrogens and androgens on reproductive development in mammals, Int J Androl, 2006;29:96–104, discussion 105–8.
EUROPEAN UROLOGICAL REVIEW
59
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84